Indian Atorvastatin Exporters: Complete Supplier Ranking with Market Share — 1291 Manufacturers (2026) — TransData Nexus

Q: Who is the largest atorvastatin buyer importing from India?

APOTEX CORP (UNITED STATES) is the largest atorvastatin importer from India with a 22.4% market share and import value of $241.6M.

Q: How many atorvastatin buyers import from India?

There are 1291 active atorvastatin buyers importing from India, with a combined import market of $1.1B across 15,000 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top atorvastatin buyers from India?

The top 5 atorvastatin buyers — APOTEX CORP, BIOMEDPHARMA, MYLAN PHARMACEUTICALS INC,, ACCORD HEALTHCARE INC.,, LIFESCIENCE LOGISTICS — together control 61.6% of total atorvastatin import value from India.

Suresh Sormare

Atorvastatin

India Pharmaceutical Trade Intelligence

$1.1B477 Suppliers145 CountriesHS 30049099

ExportsIndia → UNITED STATES52.5%India → CANADA25.9%

ImportsCROATIA → India$3.5M CANADA → India$2.5M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: APOTEX CORP

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $567.7M through 1,877 shipments. This represents a market share of 52.5% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• APOTEX CORP - $241.6M (42.6% of country's total business)

• MYLAN PHARMACEUTICALS INC, - $136.0M (24.0% of country's total business)

• LIFESCIENCE LOGISTICS - $36.4M (6.4% of country's total business)

• ASCEND LABOATORIES,LLC C/O UPS - $28.0M (4.9% of country's total business)

• NOVADOZ PHARMACEUTICALS LLC - $17.3M (3.0% of country's total business)

• Rest of United States's importers - $108.4M (19.1% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $302.4K, indicating premium pricing strategy compared to the market average of $72.0K.

United States is a key market for Atorvastatin imports, representing 52.5% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Atorvastatin buyer market intelligence

1Buyer Segment Analysis

The 1,291 buyers of Atorvastatin imported from India can be categorized into several segments:

1. Distributors: Entities like APOTEX CORP (United States, $241.63M) and BIOMEDPHARMA (Canada, $194.21M) function as intermediaries, purchasing large quantities to supply to various healthcare providers. Their buying behavior is characterized by bulk orders and a high repeat purchase rate, ensuring a steady supply chain.

2. Contract Manufacturers: Companies such as MYLAN PHARMACEUTICALS INC. (United States, $136.03M) and ACCORD HEALTHCARE INC. (Canada, $57.64M) procure Atorvastatin for formulation and packaging under their brand names. They typically engage in consistent, large-scale purchases aligned with their production schedules.

3. Re-exporters: Entities like APL SWIFT SERVICES (Malta) LTD. (Malta, $27.55M) and YUSEN LOGISTICS BENELUX BELGIUM (Belgium, $14.69M) import Atorvastatin for redistribution to other markets. Their purchasing patterns are influenced by global demand fluctuations and trade agreements.

4. Retail Chains and Hospital Groups: While not explicitly listed among the top buyers, these segments procure Atorvastatin through distributors or directly for patient care. Their orders are typically smaller and more frequent, based on patient demand and prescription trends.

5. Government Procurement: Organizations like UNICEF and national health departments may engage in tender-based purchasing for public health programs. Their procurement is often large-scale but less frequent, aligned with budget cycles and public health initiatives.

TransData Nexus Research · Government and regulatory sources

Country-Specific Import Regulations

TransData Nexus Atorvastatin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process: Importers must ensure that Atorvastatin is FDA-approved and manufactured in FDA-inspected facilities. The FDA regulates all human and animal drugs in the United States.

3. Estimated Timeline for Registration: The FDA's drug approval process can take several months to years, depending on the complexity of the application and the need for inspections.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally duty-free in the United States.

Canada

1. Drug Regulatory Authority: Health Canada.

2. Import Registration Process: Importers must obtain a Drug Establishment License (DEL) and ensure that Atorvastatin complies with the Food and Drugs Act and Regulations. Health Canada maintains a list of drugs for exceptional importation and sale, which is updated as required. (canada.ca)

3. Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and any required inspections.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are typically duty-free in Canada.

Malta

1. Drug Regulatory Authority: Malta Medicines Authority.

2. Import Registration Process: Importers must ensure that Atorvastatin is authorized for sale in Malta, complying with the Medicines Act and subsidiary legislation.

3. Estimated Timeline for Registration: The registration process can take several months, subject to the evaluation of the application and any necessary inspections.

4. Import Tariff/Duty for HS 30049099: As a member of the European Union, Malta applies the EU's Common External Tariff, which generally imposes no duties on pharmaceutical products under HS code 30049099.

Demand Drivers & Market Opportunity

TransData Nexus Atorvastatin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Atorvastatin in importing countries is driven by several factors:

1. Disease Prevalence: Cardiovascular diseases (CVDs) are the leading cause of death globally, accounting for approximately 17.9 million deaths annually. Atorvastatin is widely prescribed to manage cholesterol levels and reduce the risk of CVDs.

2. Government Healthcare Programs: Many countries have national health programs that subsidize or provide free access to essential medicines, including Atorvastatin, to manage public health concerns related to heart disease.

3. Universal Health Coverage Expansion: The global push towards Universal Health Coverage (UHC) has led to increased access to essential medicines. The WHO emphasizes the importance of essential medicines in achieving UHC, noting that over 150 countries have adopted national lists based on the WHO Model List. (who.int)

4. WHO Essential Medicines List Procurement: Atorvastatin is included in the WHO Model List of Essential Medicines, guiding countries in their procurement strategies to ensure the availability of critical medications. (iris.who.int)

5. Tender-Based Purchasing: Government and international organizations often procure medicines through tenders to ensure cost-effectiveness and supply chain stability. The presence of 1,291 buyers across 145 countries indicates a robust and diverse market for Atorvastatin, reflecting its global importance in managing cardiovascular health.

In summary, the buyer landscape for Atorvastatin imported from India is diverse, encompassing distributors, contract manufacturers, re-exporters, and healthcare providers. Understanding the import regulations of key markets and the factors driving demand is crucial for stakeholders aiming to navigate and succeed in the global pharmaceutical market.

Common Questions — Atorvastatin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest atorvastatin buyer importing from India?

Based on import volume and value, APOTEX CORP (UNITED STATES) leads with $241.6M in imports and a 22.4% market share — the highest of any single atorvastatin importer. BIOMEDPHARMA (CANADA) and MYLAN PHARMACEUTICALS INC, (UNITED STATES) are the next largest buyers.

QHow many companies buy atorvastatin from India?

There are 1291 active atorvastatin buyers importing from India, with a combined market of $1.1B across 15,000 shipments to 145 countries. The top 5 buyers hold 61.6% of total import value, while the remaining 1286 buyers handle the other 38.4%.

QWhich countries import the most atorvastatin from India?

The top importing countries for atorvastatin from India are United States (52.5%), Canada (25.9%), Malta (3.0%), United Kingdom (2.8%), Japan (2.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of atorvastatin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for atorvastatin from India?

The average import transaction value for atorvastatin from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Atorvastatin buyer market intelligence

1Buyer Segment Analysis

The 1,291 buyers of Atorvastatin imported from India can be categorized into several segments:

TransData Nexus Research · Government and regulatory sources

Country-Specific Import Regulations

TransData Nexus Atorvastatin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

3. Estimated Timeline for Registration: The FDA's drug approval process can take several months to years, depending on the complexity of the application and the need for inspections.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally duty-free in the United States.

Canada

1. Drug Regulatory Authority: Health Canada.

3. Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and any required inspections.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are typically duty-free in Canada.

Malta

1. Drug Regulatory Authority: Malta Medicines Authority.

2. Import Registration Process: Importers must ensure that Atorvastatin is authorized for sale in Malta, complying with the Medicines Act and subsidiary legislation.

3. Estimated Timeline for Registration: The registration process can take several months, subject to the evaluation of the application and any necessary inspections.

Demand Drivers & Market Opportunity

TransData Nexus Atorvastatin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Atorvastatin in importing countries is driven by several factors:

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Atorvastatin

Atorvastatin

Who Buys Atorvastatin from India — 1291 Importers Behind a $1.1B Market

Top Atorvastatin Importers — Ranked by Import Value

Top Atorvastatin Buyers & Importers

Related Analysis

Need Details?

Atorvastatin — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Atorvastatin — and from which countries?

Atorvastatin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Atorvastatin Buyers & Importers

QWho is the largest atorvastatin buyer importing from India?

QHow many companies buy atorvastatin from India?

QWhich countries import the most atorvastatin from India?

QWhat is the average import order value for atorvastatin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Canada

3Malta

4United Kingdom

5Japan

Analysis Methodology